FDA inspection
Aspire Pharmaceuticals, Inc.: FDA inspection ending Jun 21, 2010
FDA inspection 668387 · Voluntary Action Indicated (VAI) · Somerset, NJ
Key facts
| Inspection ID | 668387 |
|---|---|
| Firm | Aspire Pharmaceuticals, Inc. |
| FEI number | 3003159106 |
| Address | 37 & 41 Veronica Ave |
| City | Somerset |
| State | NJ |
| ZIP | 08873 |
| Country | United States |
| Fiscal year | 2010 |
| Inspection end date | Jun 21, 2010 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Food Composition, Standards, Labeling and Econ |
| Product type | Food/Cosmetics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data